default author photo

Alessandra Iurlo

affiliation not provided to SSRN

  • affiliation not provided to SSRN

SCHOLARLY PAPERS

2

DOWNLOADS

95

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Cytopenias and Large Splenomegaly are Main Drivers of Poor Outcome after Discontinuation of Ruxolitinib in Chronic Phase Myelofibrosis

Number of pages: 26 Posted: 07 Feb 2025
Francesca Palandri, Massimo Breccia, Erika Morsia, Elena M. Elli, Giulia Benevolo, Mario tiribelli, Eloise Beggiato, Mirko farina, Giovanni Caocci, Novella Pugliese, Alessia Tieghi, Monica Crugnola, Gianni Binotto, Francesco Cavazzini, Elisabetta Abruzzese, Alessandro Isidori, Alessandra Dedola, Alessandra Iurlo, Roberto Massimo Lemoli, Daniela Cilloni, Monica Bocchia, Florian H. Heidel, Massimiliano Bonifacio, Giuseppe A. Palumbo and Filippo Branzanti
Universitaria di Bologna - Azienda Ospedaliero, Sapienza University - Hematology, Department of Translational and Precision Medicine, affiliation not provided to SSRN, Ospedale San Gerardo, affiliation not provided to SSRN, University of Udine, affiliation not provided to SSRN, University of Brescia, affiliation not provided to SSRN, University of Naples Federico II, affiliation not provided to SSRN, University of Parma, University of Padua, University of Ferrara, University of Rome Tor Vergata, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, IRCCS Ospedale Policlinico San Martino, affiliation not provided to SSRN, University of Siena, Hannover Medical School, University of Verona, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 61 (980,173)

Abstract:

Loading...

Cytopenia, Ruxolitinib, Myelofibrosis, Splenomegaly

2.

Association of Hypomethylating Agents + Venetoclax in the Real-Life Treatment of Myeloproliferative Neoplasms in Blastic Phase

Number of pages: 24 Posted: 29 Dec 2025
roberto latagliata, Novella Pugliese, Dorela Lame, Gianluca Cristiano, Giulia De Luca, Alda Strazimiri, Fabrizio Cavalca, Lorenzo Rizzo, Simone Zoletto, Vincenzo Federico, Daniele Cattaneo, Monica Crugnola, Annalisa Biagi, Pasquale Niscola, Raffaele Palmieri, Olga Mulas, Beatrice Esposito Vangone, Michelina Santopietro, Antonella Bruzzese, Mario tiribelli, Ambra Di Veroli, Fabio Stagno, Lucia Ciuffreda, Alessandra Iurlo, Nicola Di Renzo, Gianni Binotto, Prassede Salutari, Marta Riva, Massimiliano Bonifacio, Elena M. Elli, Antonio Curti and Antonella Poloni
affiliation not provided to SSRN, University of Naples Federico II, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, ASST - Monza - San Gerardo Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Milan, University of Parma, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Udine, affiliation not provided to SSRN, G Martino University Hospital of Messina, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Padua, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Verona, Ospedale San Gerardo, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 34 (1,304,549)

Abstract:

Loading...

myeloproliferative neoplasms, blastic phase, Venetoclax, hypomethylating agents